Woerner P. Meehan, Ph.D. earned his B.S. in Biology from the University of California, Irvine and his Ph.D. in Physiology and Biophysics from the University of Southern California where he studied the effects of psychosocial stress on cardiovascular disease. He did a postdoc at Tufts University in psychopharmacology studying the interactions of anti-hypertensive drugs and aggressive behavior in animals. Dr. Meehan worked in the Departments of Medicine at USC and UCLA measuring the actions of anti-diabetes drugs on atherosclerosis and taught Gerontology at both schools. He moved to Seattle to work at Zymogenetics to do preclinical work on drugs affecting the cardiovascular system. From there he joined Artemisia BioMedical, Inc., a startup biotech that was repurposing a potent anti-malarial drug, artemisinin, to treat cancer. He recently retired from being a Nutrition Capstone Consultant for Northwest Health Sciences University.
He is a member of the University Sunrise Rotary Club.
